Wedbush Starts iTeos Therapeutics (ITOS) at Outperform

August 18, 2020 6:43 AM EDT
Get Alerts ITOS Hot Sheet
Price: $27.46 +0.44%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 13 | New: 22
Trade Now! 
Join SI Premium – FREE

Wedbush analyst David Nierengarten initiates coverage on iTeos Therapeutics (NASDAQ: ITOS) with a Outperform rating and a price target of $45.00.

For an analyst ratings summary and ratings history on iTeos Therapeutics click here. For more ratings news on iTeos Therapeutics click here.

Shares of iTeos Therapeutics closed at $32.92 yesterday.

You May Also Be Interested In

Related Categories

New Coverage